An altered ratio of membrane/cytoplasm to nuclear AT1R expression has already been observed in patients with a neuropathological diagnosis of PD who had not yet developed clinical manifestations or significant dopaminergic neurodegeneration (267). This evidence concerns the gene AGTR1 and Parkinson disease.